Detalhe da pesquisa
1.
Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients.
Oncogene
; 43(15): 1098-1112, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388710